Nevirapine levels after discontinuation of rifampicin therapy and 60-week efficacy of nevirapine-based antiretroviral therapy in HIV-infected patients with tuberculosis

by Weerawat Manosuthi, Kiat Ruxrungtham, Sirirat Likanonsakul, Wisit Prasithsirikul, Yaowarat Inthong, Thanongsri Phoorisri, Somnuek Sungkanuparph
Published 2018

Incidence and risk factors of nevirapine-associated skin rashes among HIV-infected patients with CD4 cell counts <250 cells/μL

by Weerawat Manosuthi, Somnuek Sungkanuparph, Somsit Tansuphaswadikul, Yaowarat Inthong, Wisit Prasithsirikul, Suthat Chottanapund, Wiroj Mankatitham, Sukanya Chimsuntorn, Chayanan Sittibusaya, Visal Moolasart, Nopphanath Chumpathat, Patamavadee Termvises, Achara Chaovavanich
Published 2018